Logo Ensign Group

Ensign Group (ENSG) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
Ensign Group · Health Care · ref. ETF XLV · 52 calls · price $173.54
🔔Price alertsCreate an alert →
What the company does: The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services.

📈 Ensign Group (ENSG) stock price

$173.54+0.5% over range
Aug 28, 25low $147.13 · high $215.83Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
0% recommend buying · 1 analysts
📊 JPI status : Ensign Group has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 ENSG price target & analyst consensusprice $174

The price target · all analysts combined (1 targets)
Highest target · 1 firm of 1$207+19.3%
Median target · of 1 targets$207+19.3%
Lowest target · 1 firm of 1$207+19.3%
Current price$173.54
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Truist Securities64% of its targets hit on this sector (109 calls tested). It aims for $207 (+19 %), call made on July 31, 2026, maturing on July 31, 2027 (28 d ago).

The 1 reliable analyst $207+19 %
How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $207 median.
The consensus · 1 ratings (last 6 months)
Strong Buy00%
Buy00%
Hold1100%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Ensign Group? The JPI assistant answers using our backtest data.

💰 Ensign Group dividend: yield, history & growth › open the full page

0.16%annual yield
📈 Steady dividend18 yrs of consecutive dividend increases
That's ~$0.26 per share per year.

📈 Ensign Group fundamentals: valuation, margins & growth › open the full page

P/E 28.4Net margin 6.9 %Revenue growth +17.3 %Fairly valued

Revenue, net income and margin per year

Revenue Net income · hover a bar for details
2022
marg. 7 %
2023
Rev +23%Profit −7%
2024
Rev +14%Profit +42%
2025
Rev +19%Profit +15%

🔎 Detailed analyses

✅ Historical analyst reliability on ENSG

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
SunTrust Robinson Humphrey 100% +52.7% 2
Cantor Fitzgerald  100% +49.5% 3
DA Davidson  100% +42.4% 3
Macquarie  100% +31.8% 3
Stephens & Co.  100% +30.8% 11
Oppenheimer  100% +28.6% 9
UBS  100% +17.4% 2
RBC Capital  75% +12.8% 12
Wells Fargo  0% -30.6% 2

📊 What $1,000 invested in Ensign Group would be worth › open the full page

In short — $1,000 invested in Ensign Group 10 years ago would be worth $7,572 today, i.e. +22%/yr on average. Best year: 2018 (+75%), worst: 2016 (-2%). Price performance, excluding dividends.

If I'd invested $1,000 in Ensign Group

InvestmentWorth todayGain
1 years ago$1,207+21%
3 years ago$1,694+69%
5 years ago$2,198+120%
→ See Ensign Group's full return history + gain calculator

Return by year (Ensign Group)

YearReturn$1,000 invested at year start
2026 (YTD)-8%$920 (-8%)
2025+31%$1,207 (+21%)
2024+18%$1,429 (+43%)
→ See Ensign Group's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Ensign Group

Loading news…

📋 All analyst calls on ENSG

■ Hold neutral · not a buy · 🎯$207
Price at call : $178.16 — gap to target +16%
Today : $173.54 — gap to target +19%
🎯 on ENSG : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Jul 30, 27
■ Hold neutral · not a buy · 🎯$202
Price at call : $167.38 — gap to target +21%
Today : $173.54 — gap to target +16%
🎯 on ENSG : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Jul 14, 27
RBC Capital 
Feb 9, 26
▲ Outperform · 🎯$222
Price at call : $203.93 — upside +9%
Today : $173.54 — upside +28%
🎯 on ENSG : 100% (9 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : Feb 9, 27
■ Hold neutral · not a buy · 🎯$215
Price at call : $199.29 — gap to target +8%
Today : $173.54 — gap to target +24%
🎯 on ENSG : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Feb 6, 27
RBC Capital 
Nov 14, 25
▲ Outperform · 🎯$206
Price at call : $177.56 — upside +16%
Today : $173.54 — upside +19%
🎯 on ENSG : 100% (9 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : Nov 14, 26
■ Hold neutral · not a buy · 🎯$200
Price at call : $179.8 — gap to target +11%
Today : $173.54 — gap to target +15%
🎯 on ENSG : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Nov 10, 26
UBS 
Nov 6, 25
▲ Buy · 🎯$220
Price at call : $182.91 — upside +20%
Today : $173.54 — upside +27%
🎯 on ENSG : 100% (2 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Nov 6, 26
▲ Overweight · 🎯$200
Price at call : $182.91 — upside +9%
Today : $173.54 — upside +15%
🎯 on ENSG : 100% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
in progress (365j)
matures : Nov 5, 26
See the other 44 calls, newest to oldest
UBS 
Sep 2, 25
▲ Buy · 🎯$205
Price at call : $171.65 — upside +19%
Today : $173.54 — upside +18%
🎯 on ENSG : 100% (2 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Sep 2, 26
UBS 
Aug 14, 25
▲ Buy · 🎯$195
Price at call : $166.17 — upside +17%
Today : $173.54 — upside +12%
Expected +17% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on ENSG : 100% (2 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+9.2%
stock +9% · XLV +23%
matured Aug 14, 26
■ Hold neutral · not a buy · 🎯$165
Price at call : $151.01 — gap to target +9%
Today : $173.54 — gap to target -5%
🎯 on ENSG : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Jul 28, 26
Stephens & Co. 
Jul 28, 25
▲ Overweight · 🎯$170
Price at call : $147.78 — upside +15%
Today : $173.54 — upside -2%
Expected +15% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+23.9%
stock +24% · XLV +24%
matured Jul 28, 26
Macquarie 
May 2, 25
▲ Outperform · 🎯$156
Price at call : $131.78 — upside +18%
Today : $173.54 — upside -10%
Expected +18% · Actual +38% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (3 calls matureds) · 📊 on Health : 80% · +19.0% (5 calls)
+38.1%
stock +38% · XLV +5%
matured May 2, 26
▲ Overweight · 🎯$160
Price at call : $129.23 — upside +24%
Today : $173.54 — upside -8%
Expected +24% · Actual +54% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+54.2%
stock +54% · XLV +7%
matured Feb 7, 26
▲ Overweight · 🎯$155
Price at call : $131 — upside +18%
Today : $173.54 — upside -11%
Expected +18% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+52.1%
stock +52% · XLV +7%
matured Feb 6, 26
Macquarie 
Feb 4, 25
▲ Outperform · 🎯$166
Price at call : $148.86 — upside +12%
Today : $173.54 — upside -4%
Expected +12% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (3 calls matureds) · 📊 on Health : 80% · +19.0% (5 calls)
+32.5%
stock +32% · XLV +4%
matured Feb 4, 26
■ Hold neutral · not a buy · 🎯$155
Price at call : $130.06 — gap to target +19%
Today : $173.54 — gap to target -11%
🎯 on ENSG : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Jan 6, 26
UBS 
Nov 21, 24
▲ Buy · 🎯$175
Price at call : $147.35 — upside +19%
Today : $173.54 — upside +1%
Expected +19% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (2 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+25.5%
stock +26% · XLV +7%
matured Nov 21, 25
RBC Capital 
Oct 28, 24
▲ Outperform · 🎯$172
Price at call : $156.91 — upside +10%
Today : $173.54 — upside -1%
Expected +10% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (9 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+16.4%
stock +16% · XLV -3%
matured Oct 28, 25
Stephens & Co. 
Oct 28, 24
▲ Overweight · 🎯$167
Price at call : $156.91 — upside +6%
Today : $173.54 — upside -4%
Expected +6% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+16.4%
stock +16% · XLV -3%
matured Oct 28, 25
■ Hold neutral · not a buy · 🎯$170
Price at call : $156.91 — gap to target +8%
Today : $173.54 — gap to target -2%
🎯 on ENSG : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Oct 28, 25
Oppenheimer 
Oct 25, 24
▲ Outperform · 🎯$168
Price at call : $151.87 — upside +11%
Today : $173.54 — upside -3%
Expected +11% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (7 calls matureds) · 📊 on Health : 53.6% · +4.5% (69 calls)
+22.8%
stock +23% · XLV -2%
matured Oct 25, 25
RBC Capital 
Oct 21, 24
▲ Outperform · 🎯$167
Price at call : $148.79 — upside +12%
Today : $173.54 — upside -4%
Expected +12% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (9 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+24.2%
stock +24% · XLV -3%
matured Oct 21, 25
Oppenheimer 
Sep 16, 24
▲ Outperform · 🎯$165
Price at call : $153.67 — upside +7%
Today : $173.54 — upside -5%
Expected +7% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on ENSG : 100% (7 calls matureds) · 📊 on Health : 53.6% · +4.5% (69 calls)
+6.9%
stock +7% · XLV -13%
matured Sep 16, 25
■ Hold neutral · not a buy · 🎯$160
Price at call : $139.54 — gap to target +15%
Today : $173.54 — gap to target -8%
🎯 on ENSG : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Jul 31, 25
■ Hold neutral · not a buy · 🎯$150
Price at call : $139.86 — gap to target +7%
Today : $173.54 — gap to target -14%
🎯 on ENSG : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Jul 15, 25
Macquarie 
Jun 28, 24
▲ Outperform · 🎯$134
Price at call : $123.69 — upside +8%
Today : $173.54 — upside -23%
Expected +8% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (3 calls matureds) · 📊 on Health : 80% · +19.0% (5 calls)
+24.7%
stock +25% · XLV -8%
matured Jun 28, 25
Oppenheimer 
May 6, 24
▲ Outperform · 🎯$135
Price at call : $116.05 — upside +16%
Today : $173.54 — upside -22%
Expected +16% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (7 calls matureds) · 📊 on Health : 53.6% · +4.5% (69 calls)
+15.1%
stock +15% · XLV -5%
matured May 6, 25
Stephens & Co. 
Apr 23, 24
▲ Overweight · 🎯$135
Price at call : $118.64 — upside +14%
Today : $173.54 — upside -22%
Expected +14% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on ENSG : 100% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+5.3%
stock +5% · XLV -2%
matured Apr 23, 25
RBC Capital 
Feb 6, 24
▲ Outperform · 🎯$133
Price at call : $117.39 — upside +13%
Today : $173.54 — upside -23%
Expected +13% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (9 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+15.8%
stock +16% · XLV +2%
matured Feb 5, 25
Oppenheimer 
Feb 2, 24
▲ Outperform · 🎯$130
Price at call : $117.97 — upside +10%
Today : $173.54 — upside -25%
Expected +10% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (7 calls matureds) · 📊 on Health : 53.6% · +4.5% (69 calls)
+20.7%
stock +21% · XLV +4%
matured Feb 1, 25
Oppenheimer 
Jan 17, 24
▲ Outperform · 🎯$127
Price at call : $116 — upside +9%
Today : $173.54 — upside -27%
Expected +9% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (7 calls matureds) · 📊 on Health : 53.6% · +4.5% (69 calls)
+17.9%
stock +18% · XLV +1%
matured Jan 16, 25
Stephens & Co. 
Oct 27, 23
▲ Overweight · 🎯$113
Price at call : $95.32 — upside +19%
Today : $173.54 — upside -35%
Expected +19% · Actual +59% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+59.3%
stock +59% · XLV +20%
matured Oct 26, 24
Berenberg 
Sep 28, 23
▲ Buy · 🎯$110
Price at call : $93.97 — upside +17%
Today : $173.54 — upside -37%
Expected +17% · Actual +53% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (1 call matured) · 📊 unranked overall
+53.4%
stock +53% · XLV +18%
matured Sep 27, 24
■ Hold neutral · not a buy · 🎯$110
Price at call : $93.28 — gap to target +18%
Today : $173.54 — gap to target -37%
🎯 on ENSG : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Sep 12, 24
■ Hold neutral · not a buy · 🎯$110
Price at call : $95.41 — gap to target +15%
Today : $173.54 — gap to target -37%
🎯 on ENSG : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Sep 4, 24
Stephens & Co. 
Aug 15, 23
▲ Overweight · 🎯$110
Price at call : $97.91 — upside +12%
Today : $173.54 — upside -37%
Expected +12% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+43.2%
stock +43% · XLV +12%
matured Aug 14, 24
RBC Capital 
Jul 31, 23
▲ Outperform · 🎯$114
Price at call : $94.7 — upside +20%
Today : $173.54 — upside -34%
Expected +20% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (9 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+48.6%
stock +49% · XLV +12%
matured Jul 30, 24
RBC Capital 
May 1, 23
▲ Outperform · 🎯$108
Price at call : $97.25 — upside +11%
Today : $173.54 — upside -38%
Expected +11% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (9 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+21.7%
stock +22% · XLV +5%
matured Apr 30, 24
Stephens & Co. 
Apr 27, 23
▲ Overweight · 🎯$112
Price at call : $97.09 — upside +15%
Today : $173.54 — upside -35%
Expected +15% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+22.3%
stock +22% · XLV +5%
matured Apr 26, 24
■ Hold neutral · not a buy · 🎯$110
Price at call : $98.4 — gap to target +12%
Today : $173.54 — gap to target -37%
🎯 on ENSG : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Apr 12, 24
Oppenheimer 
Feb 3, 23
▲ Outperform · 🎯$115
Price at call : $92.4 — upside +24%
Today : $173.54 — upside -34%
Expected +24% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (7 calls matureds) · 📊 on Health : 53.6% · +4.5% (69 calls)
+27.7%
stock +28% · XLV +7%
matured Feb 3, 24
Oppenheimer 
Jan 19, 23
▲ Outperform · 🎯$110
Price at call : $93.16 — upside +18%
Today : $173.54 — upside -37%
Expected +18% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (7 calls matureds) · 📊 on Health : 53.6% · +4.5% (69 calls)
+26.1%
stock +26% · XLV +5%
matured Jan 19, 24
RBC Capital 
Nov 1, 22
▲ Outperform · 🎯$102
Price at call : $91.69 — upside +11%
Today : $173.54 — upside -41%
Expected +11% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on ENSG : 100% (9 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+5.3%
stock +5% · XLV -6%
matured Nov 1, 23
Stephens & Co. 
Oct 28, 22
▲ Overweight · 🎯$101
Price at call : $89.78 — upside +12%
Today : $173.54 — upside -42%
Expected +12% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on ENSG : 100% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+6.2%
stock +6% · XLV -7%
matured Oct 28, 23
Stifel 
Sep 15, 22
▲ Buy · 🎯$105
Price at call : $84.95 — upside +24%
Today : $173.54 — upside -39%
Expected +24% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on ENSG : 100% (1 call matured) · 📊 on Health : 48% · +12.4% (98 calls)
+9.4%
stock +9% · XLV +3%
matured Sep 15, 23
RBC Capital 
Aug 3, 22
▲ Outperform · 🎯$95
Price at call : $83.87 — upside +13%
Today : $173.54 — upside -45%
Expected +13% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (9 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+15.6%
stock +16% · XLV +1%
matured Aug 3, 23
■ Hold neutral · not a buy · 🎯$85
Price at call : $73.63 — gap to target +15%
Today : $173.54 — gap to target -51%
🎯 on ENSG : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Jul 14, 23
RBC Capital 
May 3, 22
▲ Outperform · 🎯$101
Price at call : $78.4 — upside +29%
Today : $173.54 — upside -42%
Expected +29% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (9 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+19.6%
stock +20% · XLV +3%
matured May 3, 23
RBC Capital 
Oct 29, 21
▲ Outperform · 🎯$96
Price at call : $78.28 — upside +23%
Today : $173.54 — upside -45%
Expected +23% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on ENSG : 100% (9 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+14.7%
stock +15% · XLV -1%
matured Oct 29, 22
Stephens & Co. 
Nov 11, 20
▲ Overweight · 🎯$79
Price at call : $64.3 — upside +23%
Today : $173.54 — upside -54%
Expected +23% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+27.8%
stock +28% · XLV +21%
matured Nov 11, 21
Stephens & Co. 
Mar 11, 13
▲ Overweight · 🎯$10.6383
Price at call : $8.26 — upside +29%
Today : $173.54 — upside -94%
Expected +29% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on ENSG : 100% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+28.1%
stock +28% · XLV +32%
matured Mar 11, 14

Frequently asked questions

Should I buy Ensign Group stock?

This isn't buy advice. For Ensign Group, the analyst consensus is "Hold", with an average price target of $207 (+19% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Ensign Group). We show the numbers — you decide.

Is it too late to buy Ensign Group? How high can it go?

The most bullish analyst target on Ensign Group is $207 (+19% above today's price); the average is $207. That's the upside they see. Check how reliable those analysts have actually been on Ensign Group on our site before trusting it.

Is Ensign Group still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 9 analysts have a real record on Ensign Group, the best hitting 100% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.

What has Ensign Group's past performance been?

Historical returns and a "how much if I had invested" calculator: ENSG performance & returns.

Does Ensign Group pay a dividend?

Yield, consistency and growth history of the dividend: ENSG's dividend.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)